These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30774454)

  • 1. Enhanced efficacy of chemically modified curcumin in experimental periodontitis: systemic implications.
    Wang HH; Lee HM; Raja V; Hou W; Iacono VJ; Scaduto J; Johnson F; Golub LM; Gu Y
    J Exp Pharmacol; 2019; 11():1-14. PubMed ID: 30774454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel chemically modified curcumin reduces inflammation-mediated connective tissue breakdown in a rat model of diabetes: periodontal and systemic effects.
    Elburki MS; Moore DD; Terezakis NG; Zhang Y; Lee HM; Johnson F; Golub LM
    J Periodontal Res; 2017 Apr; 52(2):186-200. PubMed ID: 27038334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Chemically Modified Curcumin (CMC 2.24) Inhibits Nuclear Factor κB Activation and Inflammatory Bone Loss in Murine Models of LPS-Induced Experimental Periodontitis and Diabetes-Associated Natural Periodontitis.
    Elburki MS; Rossa C; Guimarães-Stabili MR; Lee HM; Curylofo-Zotti FA; Johnson F; Golub LM
    Inflammation; 2017 Aug; 40(4):1436-1449. PubMed ID: 28534138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel chemically modified curcumin reduces severity of experimental periodontal disease in rats: initial observations.
    Elburki MS; Rossa C; Guimaraes MR; Goodenough M; Lee HM; Curylofo FA; Zhang Y; Johnson F; Golub LM
    Mediators Inflamm; 2014; 2014():959471. PubMed ID: 25104884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-methoxycarbonyl curcumin: a unique inhibitor of both inflammatory mediators and periodontal inflammation.
    Gu Y; Lee HM; Napolitano N; Clemens M; Zhang Y; Sorsa T; Zhang Y; Johnson F; Golub LM
    Mediators Inflamm; 2013; 2013():329740. PubMed ID: 24453415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review.
    Kaur S; White S; Bartold M
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-12. PubMed ID: 27820156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemically-Modified Curcumin 2.24: A Novel Systemic Therapy for Natural Periodontitis in Dogs.
    Deng J; Golub LM; Lee HM; Lin MC; Bhatt HD; Hong HL; Johnson F; Scaduto J; Zimmerman T; Gu Y
    J Exp Pharmacol; 2020; 12():47-60. PubMed ID: 32104105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Chemically Modified Curcumin Control the Progression of Periodontitis? A Systematic Review.
    Dhaifullah E; Seayed HS; Mostafa D; Alharbi AMM; Alotaibi WM
    J Exp Pharmacol; 2021; 13():565-575. PubMed ID: 34135646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response assessment of chemically modified curcumin in experimental periodontitis.
    de Almeida Brandão D; Spolidorio LC; Johnson F; Golub LM; Guimarães-Stabili MR; Rossa C
    J Periodontol; 2019 May; 90(5):535-545. PubMed ID: 30394523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and laminin-5 gamma2 chain immunolocalization in gingival tissue of endotoxin-induced periodontitis in rats: effects of low-dose doxycycline and alendronate.
    Buduneli E; Vardar-Sengül S; Buduneli N; Atilla G; Wahlgren J; Sorsa T
    J Periodontol; 2007 Jan; 78(1):127-34. PubMed ID: 17199549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of selective COX-2 inhibitor/celecoxib and omega-3 fatty acid on matrix metalloproteinases, TIMP-1, and laminin-5gamma2-chain immunolocalization in experimental periodontitis.
    Vardar-Sengul S; Buduneli E; Turkoglu O; Buduneli N; Atilla G; Wahlgren J; Sorsa T; Baylas H
    J Periodontol; 2008 Oct; 79(10):1934-41. PubMed ID: 18834249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect and related mechanisms of curcumin in rat experimental periodontitis.
    Xiao CJ; Yu XJ; Xie JL; Liu S; Li S
    Head Face Med; 2018 Aug; 14(1):12. PubMed ID: 30115081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Modified-Curcumin Promotes Resolvin-Like Activity and Reduces Bone Loss in Diabetes-Induced Experimental Periodontitis.
    Deng J; Golub LM; Lee HM; Raja V; Johnson F; Kucine A; Lee W; Xu TM; Gu Y
    J Inflamm Res; 2021; 14():5337-5347. PubMed ID: 34703272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of natural Curcumin and chemically modified curcumin on inflammation and bone resorption in model of experimental periodontitis.
    Curylofo-Zotti FA; Elburki MS; Oliveira PA; Cerri PS; Santos LA; Lee HM; Johnson F; Golub LM; Rossa C; Guimarães-Stabili MR
    Arch Oral Biol; 2018 Jul; 91():42-50. PubMed ID: 29669267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines.
    Ramamurthy NS; Rifkin BR; Greenwald RA; Xu JW; Liu Y; Turner G; Golub LM; Vernillo AT
    J Periodontol; 2002 Jul; 73(7):726-34. PubMed ID: 12146531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periodontal therapeutics: Current host-modulation agents and future directions.
    Golub LM; Lee HM
    Periodontol 2000; 2020 Feb; 82(1):186-204. PubMed ID: 31850625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine's effect on periodontal tissue degradation by matrix metalloproteinases: an in vitro and in vivo experiment.
    Tu HP; Fu MM; Kuo PJ; Chin YT; Chiang CY; Chung CL; Fu E
    Phytomedicine; 2013 Oct; 20(13):1203-10. PubMed ID: 23867651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic treatment with resveratrol and/or curcumin reduces the progression of experimental periodontitis in rats.
    Corrêa MG; Pires PR; Ribeiro FV; Pimentel SZ; Casarin RC; Cirano FR; Tenenbaum HT; Casati MZ
    J Periodontal Res; 2017 Apr; 52(2):201-209. PubMed ID: 27135637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination of a chemically modified doxycycline and a bisphosphonate synergistically inhibits endotoxin-induced periodontal breakdown in rats.
    Llavaneras A; Ramamurthy NS; Heikkilä P; Teronen O; Salo T; Rifkin BR; Ryan ME; Golub LM; Sorsa T
    J Periodontol; 2001 Aug; 72(8):1069-77. PubMed ID: 11525440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of low-dose doxycycline and bisphosphonate clodronate on alveolar bone loss and gingival levels of matrix metalloproteinase-9 and interleukin-1β in rats with diabetes: a histomorphometric and immunohistochemical study.
    Ozdemir SP; Kurtiş B; Tüter G; Bozkurt Ş; Gültekin SE; Sengüven B; Watanabe K; Aydın S
    J Periodontol; 2012 Sep; 83(9):1172-82. PubMed ID: 22220769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.